Edition:
India

Jiang Zhong Pharmaceutical Co Ltd (600750.SS)

600750.SS on Shanghai Stock Exchange

16.56CNY
24 May 2019
Change (% chg)

¥0.20 (+1.22%)
Prev Close
¥16.36
Open
¥16.37
Day's High
¥16.61
Day's Low
¥16.30
Volume
2,323,642
Avg. Vol
6,267,768
52-wk High
¥20.39
52-wk Low
¥13.80

Latest Key Developments (Source: Significant Developments)

Jiang Zhong Pharma Says China Resources Pharmaceutical Offers To Buy 239.3 Mln Shares In The Company
Wednesday, 27 Feb 2019 

Feb 27 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS CHINA RESOURCES PHARMACEUTICAL HOLDINGS OFFERS TO BUY UP TO 239.3 MILLION SHARES IN THE COMPANY AT 17.56 YUAN ($2.63) PER SHARE.SAYS THE BID OFFER COMES AFTER CHINA RESOURCES PHARMACEUTICAL'S HOLDINGS IN THE COMPANY REACHED OVER 30 PERCENT.  Full Article

Jiang Zhong Pharmaceutical's Preliminary 2018 Net Profit Up 10.6 Percent Y/Y
Tuesday, 15 Jan 2019 

Jan 15 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS PRELIM 2018 NET PROFIT UP 10.6 PERCENT Y/Y AT 462.2 MILLION YUAN ($68.41 million).  Full Article

Jiang Zhong Pharmaceutical To Invest 376.7 Million Yuan In Two Pharma Firms
Thursday, 3 Jan 2019 

Jan 3 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS IT SIGNS AGREEMENTS TO INVEST A COMBINED 376.7 MILLION YUAN ($54.82 million) IN TWO PHARMA FIRMS FOR 51 PERCENT STAKE EACH.  Full Article

Jiang Zhong Pharmaceutical Signs Framework Agreement To Buy Stakes In Jiangxi Sanghai's Units
Friday, 27 Jul 2018 

July 27 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS IT SIGNS FRAMEWORK AGREEMENT TO BUY JIANGXI SANGHAI GROUP'S TWO UNITS' STAKES OF 51 PERCENT EACH.  Full Article

China Resources Pharmaceutical Group Updates On Buying Controlling Stake In Jiangzhong Group
Monday, 4 Jun 2018 

June 4 (Reuters) - China Resources Pharmaceutical Group Ltd <3320.HK>::UPDATES ON RESTRUCTURE WHEREBY CO WILL ACQUIRE CONTROLLING STAKE IN JIANGZHONG GROUP.OFFER PRICE OF FOR GENERAL OFFER FOR JIANGZHONG PHARMACEUTICAL CO SHALL BE RMB25.03 PER SHARE.TOTAL MAXIMUM CAPITAL AMOUNT NEEDED FOR OFFER IS RMB4.28 BILLION.NUMBER OF SHARES SUBJECT TO OFFER IS 170.9 MILLION LISTED TRADABLE SHARES OF JIANGZHONG PHARMACEUTICAL.COMPLETION OF PROPOSED ACQUISITION WILL TRIGGER OBLIGATION OF GENERAL OFFER FOR SHARES OF JIANGZHONG PHARMA.  Full Article

Jiang Zhong Pharmaceutical Says Owner's Proposal May Lead To Change Of Company's Ownership
Tuesday, 15 May 2018 

May 15 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS OWNER'S PROPOSAL MAY LEAD TO CHANGE OF CO'S OWNERSHIP, TRADING IN SHARES REMAINS SUSPENDED.  Full Article

Jiang Zhong Pharmaceutical's Chairman And General Manager Zhong Hongguang Retires
Tuesday, 27 Mar 2018 

March 27 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS ITS CHAIRMAN AND GENERAL MANAGER ZHONG HONGGUANG RETIRES.  Full Article

Jiang Zhong Pharmaceutical's Prelim 2017 Net Profit Up 10 Percent Y/Y
Friday, 19 Jan 2018 

Jan 19 (Reuters) - Jiang Zhong Pharmaceutical Co Ltd <600750.SS>::SAYS PRELIM 2017 NET PROFIT UP 10 PERCENT Y/Y AT 418.0 MILLION YUAN ($65.38 million).  Full Article